{"organizations": [], "uuid": "bd849abc049e4ebbb0621b6b092c5518fe3a733c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180227.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-vistin-pharma-q4-adjusted-ebitda-l/brief-vistin-pharma-q4-adjusted-ebitda-loss-widens-to-nok-1-6-million-idUSFWN1QH01D", "country": "US", "domain_rank": 408, "title": "BRIEF-Vistin Pharma Q4 Adjusted EBITDA Loss Widens To NOK ‍1.6​ Million", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T14:09:00.000+02:00", "replies_count": 0, "uuid": "bd849abc049e4ebbb0621b6b092c5518fe3a733c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-vistin-pharma-q4-adjusted-ebitda-l/brief-vistin-pharma-q4-adjusted-ebitda-loss-widens-to-nok-1-6-million-idUSFWN1QH01D", "ord_in_thread": 0, "title": "BRIEF-Vistin Pharma Q4 Adjusted EBITDA Loss Widens To NOK ‍1.6​ Million", "locations": [], "entities": {"persons": [{"name": "vistin", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-vistin pharma", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 27 (Reuters) - VISTIN PHARMA ASA:\n* Q4 REVENUE NOK ‍41.6​ MILLION VERSUS NOK 32.5 MILLION YEAR AGO\n* Q4 ADJUSTED EBITDA LOSS FROM CONTINUING. OPERATIONS NOK ‍1.6​ MILLION VERSUS LOSS NOK 1.0 MILLION YEAR AGO\n* THE BOARD WILL PROPOSE A DIVIDEND OF NOK 17.1 MILLION (NOK 1.00 PER SHARE) FOR 2017‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T14:09:00.000+02:00", "crawled": "2018-02-28T13:04:51.002+02:00", "highlightTitle": ""}